ANI Pharmaceuticals | ANIP - Trade Creditors


ANI Pharmaceuticals reported $69.69M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
ANI Pharmaceuticals USD 69.69M 7.11M Mar/2026
Aurora Cannabis CAD 68.03M 18.68M Dec/2025
Canopy Growth CAD 19.96M 1.83M Dec/2025
Eli Lilly USD 5.03B 350M Mar/2026
Emergent BioSolutions USD 112.2M 500K Dec/2023
Heron Therapeutics USD 8.97M 24K Mar/2026
Hikma Pharmaceutical USD 715M 104M Dec/2025
Knight Therapeutics CAD 125.76M 7.63M Dec/2025
Nektar Therapeutics USD 10.77M 4.79M Dec/2025
Novartis USD 4.46B 99M Dec/2025
Omeros USD 8.84M 4.42M Jun/2025
Perrigo USD 434.8M 39.7M Mar/2026
Sun Pharmaceuticals INR 73.34B 6.28B Mar/2026
Teva Pharmaceutical Industries USD 2.6B 65M Mar/2026